Gazzard B - Search Results

1

Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study).

Sullivan AK, Raben D, Reekie J, Rayment M, Mocroft A, Esser S, Leon A, Begovac J, Brinkman K, Zangerle R, Grzeszczuk A, Vassilenko A, Hadziosmanovic V, Krasnov M, Sönnerborg A, Clumeck N, Gatell J, Gazzard B, Monforte Ad, Rockstroh J, Lundgren JD. Sullivan AK, et al. Among authors: gazzard b. PLoS One. 2013;8(1):e52845. doi: 10.1371/journal.pone.0052845. Epub 2013 Jan 15. PLoS One. 2013. PMID: 23341910 Free PMC article.

2

Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune).

Pido-Lopez J, Burton C, Hardy G, Pires A, Sullivan A, Gazzard B, Aspinall R, Gotch F, Imami N. Pido-Lopez J, et al. Among authors: gazzard b. AIDS Res Hum Retroviruses. 2003 Feb;19(2):103-9. doi: 10.1089/088922203762688603. AIDS Res Hum Retroviruses. 2003. PMID: 12639245

3

Tetanus vaccination with IL-2 during highly active antiretroviral therapy induces sustained and pronounced specific CD4 T-cell responses.

Hardy GA, Imami N, Sullivan AK, Nelson MR, Gazzard B, Gotch FM. Hardy GA, et al. Among authors: gazzard b. AIDS. 2004 Nov 5;18(16):2199-202. doi: 10.1097/00002030-200411050-00014. AIDS. 2004. PMID: 15577655

4

Hepatitis C infection is not associated with systemic HIV-associated non-Hodgkin's lymphoma: a cohort study.

Waters L, Stebbing J, Mandalia S, Young AM, Nelson M, Gazzard B, Bower M. Waters L, et al. Among authors: gazzard b. Int J Cancer. 2005 Aug 10;116(1):161-3. doi: 10.1002/ijc.20988. Int J Cancer. 2005. PMID: 15756687 Free article.

5

A phase I, randomized study of combined IL-2 and therapeutic immunisation with antiretroviral therapy.

Hardy GA, Imami N, Nelson MR, Sullivan AK, Moss R, Aasa-Chapman MM, Gazzard B, Gotch FM. Hardy GA, et al. Among authors: gazzard b. J Immune Based Ther Vaccines. 2007 Apr 11;5:6. doi: 10.1186/1476-8518-5-6. J Immune Based Ther Vaccines. 2007. PMID: 17428345 Free PMC article.

6

Fungal infection as a risk factor for HIV disease progression among patients with a CD4 count above 200/microl in the era of cART.

Podlekareva D, Mocroft A, Kirk O, Reiss P, Aldins P, Katlama C, Kovari H, Stellbrink HJ, D'Arminio Monforte A, Lundgren JD; Eurosida Study Group. Podlekareva D, et al. Scand J Infect Dis. 2008;40(11-12):908-13. doi: 10.1080/00365540802227094. Scand J Infect Dis. 2008. PMID: 18609197

7

The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published results.

Podlekareva D, Bannister W, Mocroft A, Abrosimova L, Karpov I, Lundgren JD, Kirk O; EuroSIDA Study Group. Podlekareva D, et al. Cent Eur J Public Health. 2008 Sep;16(3):99-105. doi: 10.21101/cejph.a3490. Cent Eur J Public Health. 2008. PMID: 18935770 Review.

8

Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?

Reekie J, Mocroft A, Sambatakou H, Machala L, Chiesi A, van Lunzen J, Clumeck N, Kirk O, Gazzard B, Lundgren JD; EuroSIDA Study Group. Reekie J, et al. Among authors: gazzard b. AIDS. 2008 Nov 12;22(17):2381-90. doi: 10.1097/QAD.0b013e328317a6eb. AIDS. 2008. PMID: 18981778

9

Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.

Kesselring AM, Wit FW, Sabin CA, Lundgren JD, Gill MJ, Gatell JM, Rauch A, Montaner JS, de Wolf F, Reiss P, Mocroft A; Nevirapine Toxicity Multicohort Collaboration. Kesselring AM, et al. AIDS. 2009 Aug 24;23(13):1689-99. doi: 10.1097/QAD.0b013e32832d3b54. AIDS. 2009. PMID: 19487907

10

Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.

Cozzi-Lepri A, Phillips AN, Martinez-Picado J, Monforte Ad, Katlama C, Eg Hansen AB, Horban A, Bruun J, Clotet B, Lundgren JD; EuroSIDA Study Group. Cozzi-Lepri A, et al. J Infect Dis. 2009 Sep 1;200(5):687-97. doi: 10.1086/604731. J Infect Dis. 2009. PMID: 19604043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

938 results

Search Page